Siemens Healthineers AG
XETRA:SHL

Watchlist Manager
Siemens Healthineers AG Logo
Siemens Healthineers AG
XETRA:SHL
Watchlist
Price: 49.8 EUR 1.36% Market Closed
Market Cap: 55.7B EUR
Have any thoughts about
Siemens Healthineers AG?
Write Note

Siemens Healthineers AG
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Siemens Healthineers AG
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Siemens Healthineers AG
XETRA:SHL
Research & Development
-€1.9B
CAGR 3-Years
-21%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Carl Zeiss Meditec AG
XETRA:AFX
Research & Development
-€352.1m
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-14%
Stratec SE
XETRA:SBS
Research & Development
-€10.3m
CAGR 3-Years
-37%
CAGR 5-Years
-11%
CAGR 10-Years
-3%
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Research & Development
-€328.1m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Sartorius AG
XETRA:SRT
Research & Development
-€185.4m
CAGR 3-Years
-23%
CAGR 5-Years
-17%
CAGR 10-Years
-15%
No Stocks Found

Siemens Healthineers AG
Glance View

Market Cap
55.6B EUR
Industry
Health Care

Siemens Healthineers AG stands at the forefront of medical technology, championing innovation in healthcare that dramatically enhances patient outcomes around the globe. Established as a subsidiary of the industrial giant Siemens AG, the company has carved out its own identity as a leader in diagnostic imaging, laboratory diagnostics, and digital health services. With a rich history spanning over a century, Siemens Healthineers has continuously evolved, investing heavily in research and development to produce cutting-edge technologies such as advanced imaging equipment like MRI and CT scanners. This relentless pursuit of excellence equips healthcare providers with the tools necessary to deliver accurate diagnoses and efficient patient care, positioning the company as a crucial player in an ever-growing healthcare market. For investors, Siemens Healthineers presents an enticing opportunity, driven by the increasing global demand for medical advancements and the aging population seeking better healthcare solutions. By capitalizing on trends like digitalization and personalized medicine, the company is poised for sustainable growth, offering a robust portfolio of products and services that cater to a diverse range of medical needs. With a strong commitment to expanding its market presence through strategic partnerships and acquisitions, Siemens Healthineers is not just a provider of medical technology; it’s a pivotal force in reshaping the future landscape of healthcare, making it an attractive investment for those looking to support innovation while reaping financial rewards.

SHL Intrinsic Value
73.51 EUR
Undervaluation 32%
Intrinsic Value
Price

See Also

What is Siemens Healthineers AG's Research & Development?
Research & Development
-1.9B EUR

Based on the financial report for Jun 30, 2024, Siemens Healthineers AG's Research & Development amounts to -1.9B EUR.

What is Siemens Healthineers AG's Research & Development growth rate?
Research & Development CAGR 5Y
-8%

Over the last year, the Research & Development growth was -2%. The average annual Research & Development growth rates for Siemens Healthineers AG have been -21% over the past three years , -8% over the past five years .

Back to Top